These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 22332689)

  • 1. Drug interactions in elderly individuals with the human immunodeficiency virus.
    Darque A; Enel P; Ravaux I; Petit N; Retornaz F
    J Am Geriatr Soc; 2012 Feb; 60(2):382-4. PubMed ID: 22332689
    [No Abstract]   [Full Text] [Related]  

  • 2. Drug interactions between psychoactive substances and antiretroviral therapy in individuals infected with human immunodeficiency and hepatitis viruses.
    Neuman MG; Monteiro M; Rehm J
    Subst Use Misuse; 2006; 41(10-12):1395-463. PubMed ID: 17002989
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Interactions of cardiac and antiretroviral medication].
    Egger S; Drewe J
    Herz; 2005 Sep; 30(6):493-503. PubMed ID: 16170680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Human immunodeficiency virus (HIV) type 1 with R5 tropism among HIV-1 antiretroviral-experienced patients in Spain].
    Arribas JR; Rivero A; Leal M; Sánchez-de la Rosa R
    Enferm Infecc Microbiol Clin; 2010 Oct; 28(8):559-60. PubMed ID: 20400209
    [No Abstract]   [Full Text] [Related]  

  • 5. Critical drug interaction between ritonavir-boosted atazanavir regimen and non-nucleoside reverse transcriptase inhibitors.
    Poirier JM; Guiard-Schmid JB; Meynard JL; Bonnard P; Zouai O; Lukiana T; Jaillon P; Girard PM; Pialoux G
    AIDS; 2006 Apr; 20(7):1087-9. PubMed ID: 16603872
    [No Abstract]   [Full Text] [Related]  

  • 6. Devolving of statin prescribing to general practitioners for HIV-infected patients receiving antiretroviral therapy.
    Benn PD; Miller RF; Evans L; Minton J; Edwards SG
    Int J STD AIDS; 2009 Mar; 20(3):202-4. PubMed ID: 19255272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An in-depth analysis of medication errors in hospitalized patients with HIV.
    Snyder AM; Klinker K; Orrick JJ; Janelle J; Winterstein AG
    Ann Pharmacother; 2011 Apr; 45(4):459-68. PubMed ID: 21487084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Emerging antiretroviral drug interactions.
    Pham PA; Flexner C
    J Antimicrob Chemother; 2011 Feb; 66(2):235-9. PubMed ID: 21131695
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Highly active antiretroviral therapy (HAART) in adults with tuberculosis: current status.
    Kwara A; Flanigan TP; Carter EJ
    Int J Tuberc Lung Dis; 2005 Mar; 9(3):248-57. PubMed ID: 15786886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Infections with human immunodeficiency viruses. Part II: Antiretroviral drugs, therapeutic options, and diagnostics].
    Stock I
    Med Monatsschr Pharm; 2011 Jul; 34(7):234-44; quiz 245-6. PubMed ID: 21809598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [AIDS Study Group/Spanish AIDS Plan consensus document on antiretroviral therapy in adults with human immunodeficiency virus infection (updated January 2010)].
    ;
    Enferm Infecc Microbiol Clin; 2010; 28(6):362.e1-91. PubMed ID: 20554079
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Interference among antiretroviral, anti-HCV, and immunosuppressive treatments].
    Peytavin G
    Med Mal Infect; 2004 Nov; 34 Spec No 2():20-1. PubMed ID: 15801535
    [No Abstract]   [Full Text] [Related]  

  • 13. Clinical management of drug addicts infected with human immunodeficiency virus and hepatitis C virus.
    Khalsa JH; Vocci F
    J Addict Dis; 2008; 27(2):1-10. PubMed ID: 18681186
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The challenge of polypharmacy in an aging population and implications for future antiretroviral therapy development.
    Smith JM; Flexner C
    AIDS; 2017 Jun; 31 Suppl 2():S173-S184. PubMed ID: 28471948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The value and challenges of improving adherence to antiretroviral therapy for human immunodeficiency virus.
    Johnson MO; Chesney MA
    Med Care; 2006 Oct; 44(10):891-2. PubMed ID: 17001258
    [No Abstract]   [Full Text] [Related]  

  • 16. [Antiretroviral therapy of HIV infection. German-Austrian guidelines (position in September 2008)].
    ;
    Dtsch Med Wochenschr; 2009 Jan; 134 Suppl 1():S4-15. PubMed ID: 19172554
    [No Abstract]   [Full Text] [Related]  

  • 17. Antiretroviral and immunosuppressive drug-drug interactions in human immunodeficiency virus-infected liver and kidney transplant recipients.
    Marfo K; Greenstein S
    Transplant Proc; 2009 Nov; 41(9):3796-9. PubMed ID: 19917390
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human immunodeficiency virus and pregnancy.
    Reshi P; Lone IM
    Arch Gynecol Obstet; 2010 May; 281(5):781-92. PubMed ID: 20035338
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low vitamin D among HIV-infected adults: prevalence of and risk factors for low vitamin D Levels in a cohort of HIV-infected adults and comparison to prevalence among adults in the US general population.
    Dao CN; Patel P; Overton ET; Rhame F; Pals SL; Johnson C; Bush T; Brooks JT;
    Clin Infect Dis; 2011 Feb; 52(3):396-405. PubMed ID: 21217186
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacokinetic interactions between buprenorphine and antiretroviral medications.
    Bruce RD; McCance-Katz E; Kharasch ED; Moody DE; Morse GD
    Clin Infect Dis; 2006 Dec; 43 Suppl 4():S216-23. PubMed ID: 17109308
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.